enzalutamide improves survival for men with metastatic hormone-sensitive prostate cancer
Published 5 years ago • 4.8K plays • Length 8:56Download video MP4
Download video MP3
Similar videos
-
6:06
enzalutamide plus androgen deprivation therapy prolongs survival in men with metastatic hormone-...
-
3:38
enzalutamide as treatment for men with mhspc who have received testosterone suppression
-
6:40
updated overall survival outcomes in enzamet (anzup 1304)
-
7:53
docetaxil in hormone therapy improves survival in metastatic, hormone-sensitive prostate cancer
-
1:46
stream trial: enzalutamide and androgen deprivation therapy with salvage radiation in men with h...
-
3:43
arches trial: androgen deprivation therapy with enzalutamide or placebo in mhspc
-
11:48
adding enzalutamide to standard first-line treatment improves survival for hormone-sensitive pro...
-
5:11
enzalutamide adt in men with de novo mhspc: the arches trial
-
4:22
fatigue in men with castration resistant prostate cancer treated with enzalutamide
-
1:55
arches trial overview: adt plus enzalutamide for metastatic hormone-sensitive prostate cancer
-
25:53
developments in metastatic hormone-sensitive prostate cancer
-
2:47
enzamet trial: early enzalutamide delays progression, improves survival in mhspc
-
18:01
clinical updates for metastatic hormone sensitive prostate cancer at asco 2019
-
2:14
prostate cancer: research shows new treatment option offers improved survival
-
5:16
enzamet: enzalutamide for metastatic prostate cancer
-
6:26
enzamet & arches trials provides evidence of enzalutamide as life prolonging therapy in mhspc
-
22:36
key developments in non-metastatic & metastatic hormone-sensitive prostate cancer
-
2:12
abiraterone for metastatic, hormone sensitive, prostate cancer
-
5:49
adt plus docetaxel or bisphosphonates in hormone sensitive prostate cancer: systemic review